PTC Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	1,731	806.78	937.82	698.8	538.59
Revenue Growth (YoY)	114.51%	-13.97%	34.20%	29.75%	41.45%
Cost of Revenue	47.01	57.4	65.49	44.68	32.33
Gross Profit	1,684	749.38	872.34	654.12	506.27
Selling, General & Admin	347.14	300.91	332.54	326	285.77
Depreciation & Amortization Expenses	24.74	60.74	222.64	116.55	54.75
Research & Development	455.25	534.48	666.56	651.5	540.68
Other Operating Expenses	-10.43	155.82	90.1	7.48	-0.5
Total Operating Expenses	816.71	1,052	1,312	1,102	880.71
Operating Income	866.94	-302.57	-439.5	-447.41	-374.44
Interest Expense	-152.23	-166.99	-129.18	-90.87	-86.02
Other Non-Operating Income (Expense)	-18.09	106.44	-127.43	-49.21	-57.88
Total Non-Operating Income (Expense)	-170.32	-60.55	-256.61	-140.08	-143.9
Pretax Income	696.62	-363.12	-696.11	-587.49	-518.34
Provision for Income Taxes	13.98	0.18	-69.51	-28.47	5.56
Net Income	682.64	-363.3	-626.6	-559.02	-523.9
Net Income to Common	682.64	-363.3	-626.6	-559.02	-523.9
Shares Outstanding (Basic)	80	77	75	72	70
Shares Outstanding (Diluted)	88	77	75	72	70
Shares Change (YoY)	14.92%	2.68%	4.33%	1.79%	6.72%
EPS (Basic)	8.58	-4.73	-8.37	-7.79	-7.43
EPS (Diluted)	7.78	-4.73	-8.37	-7.79	-7.43
Free Cash Flow	702.34	-114.19	-186.86	-388.67	-279.55
Free Cash Flow Per Share	7.95	-1.49	-2.50	-5.42	-3.97
Gross Margin	97.28%	92.89%	93.02%	93.61%	94.00%
Operating Margin	50.09%	-37.50%	-46.86%	-64.03%	-69.52%
Profit Margin	39.44%	-45.03%	-66.81%	-80.00%	-97.27%
FCF Margin	40.58%	-14.15%	-19.92%	-55.62%	-51.90%
EBITDA	905.75	-226.91	-202.91	-318.57	-310.31
EBITDA Margin	52.34%	-28.13%	-21.64%	-45.59%	-57.61%
EBIT	866.94	-302.57	-439.5	-447.41	-374.44
EBIT Margin	50.09%	-37.50%	-46.86%	-64.03%	-69.52%
Effective Tax Rate	2.01%	-0.05%	9.98%	4.85%	-1.07%

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q